
Diet getting healthier Researchers from Newcastle-upon-Tyne, UK, concluded that people who were
children 20 years ago have adopted better diets as they have got older. The findings come from a study of 200 schoolchildren aged 11 or 12 conducted
about 20 years ago. In the 1980s researchers asked the schoolchildren to keep detailed diaries
of their eating habits - and asked them again in their early 30s. Reporting in the journal Appetite, the researchers said many young adults
believed they were too busy to eat a healthy diet. But, in fact, those who were raised to eat fruit and vegetables ate more
than ever as adults. One example is Neil a police officer who used to combine a breakfast
cereal with a sweet and a boiled egg for breakfast as a child. As an adult he now has cereal and a banana for breakfast and uses skimmed
milk. He said: "My parents always put a good meal on the table but I just
wasn't interested in eating well. As a kid I didn't often have breakfast
– I just went off to school, and I ate far too many sweets. "Now I see breakfast as a really important meal of the day and I
make sure that it's healthy." Researcher Amelia Lake, of Newcastle University, said: "A lot depends
on people's individual coping mechanisms and attitude to life. A lack
of time is not necessarily the reason for people not attempting to eat
healthily. "Some working adults are inspired to make a healthy meal in the
evenings, while somebody with the same amount of time on their hands would
feel under pressure and be inclined to send out for a takeaway. "These results suggest that the diet is really up to the individual
and their personality, and that general health messages are not necessarily
enough when a variety of factors are working to prevent people from eating
healthily." Crohn's disease linked to TB bug Crohn's disease is a form of inflammatory bowel disease (IBD) with at
least one million sufferers worldwide. It has some similarities with tuberculosis, leprosy, and paratuberculosis,
and has now been strongly linked to Mycobacterium avium subspecies paratuberculosis
(MAP). MAP was first identified in a person with Crohn's disease 20 years
ago, but its role is still unclear. Dr Saleh Naser and colleagues at the University of Central Florida, Orlando,
USA looked for the presence of MAP in the blood of IBD patients and healthy
controls. They found live MAP in 50 per cent of Crohn's disease patients, 22 per
cent of those with the IBD ulcerative colitis, and none of the controls.
Results are published in this week's issue of the Lancet. Dr Naser says, "Detection of viable MAP in the blood of Crohn's
disease patients suggests that MAP infection in this IBD may be systemic.
A multi-centre, larger-scale investigation is urgently needed." Also in the Lancet is a commentary by Professor Warwick Selby of the
University of Sydney, Australia. He writes, "This report by Naser et al may still fall short of proving
that MAP is one of the causes of Crohn's disease but as with similar studies
it raises many important questions. The findings now need to be replicated
in other laboratories. Whatever one's view, MAP cannot continue to be
ignored in Crohn's disease. "Funding bodies, laboratory and clinical researchers must clarify
with some urgency, once and for all, whether this organism is important
in Crohn's disease or is merely a curious bystander." Lancet Vol 364(9439) 18–24 September 2004 pp 1013, 1039 Plea for haemophilia cure The Katherine Dormandy Trust, based in London, UK, believes that a genetic
cure for the disease is very close. It launched an appeal for five million UK pounds to enable researchers
to start treating patients with new genetic cures. The trust said potential genetic cures for haemophilia already exist
in laboratories. The trust said a cure would prove highly cost effective for the British
health services which can spend some five million UK pounds on treatment
over the lifetime of a patient with haemophilia. Its chairman Professor Ted Tuddenham, director of the UK Medical Research
Council's haemostasis and thrombosis research group, said: "The KD
Trust has reviewed results of key world-wide gene therapy for haemophilia
research projects, noting the strengths, weaknesses and wide variety of
techniques developed so far. "It is now clear that there are highly promising projects, led by
UK scientists financially supported in part by the KD Trust, that have
produced this cure. "This means that a cure in humans could be just a few years away." Dr Katherine Dormandy died from cancer at the age of 53 in 1978 five
years after setting up the trust. Flower tea may fight cholesterol The hibiscus flower is already used by herbalists as a treatment for
high blood pressure and liver disease. But a study conducted in Taiwan has come up with evidence that it may
prevent the harmful effects of cholesterol on the arteries. The study, using laboratory rats, showed that the tea prevented the oxidation
of low density lipoprotein, the unhealthy form of cholesterol. The oxidation process is thought to contribute to the narrowing of arteries
and heart disease. The tea also reduced overall levels of cholesterol, the researchers report
in the Journal of Science of Food and Agriculture. Researcher Chau-Jong Wang, of Chung Shan Medical University, said: "Experiments
have shown that compounds extracted from red wine and tea reduces cholesterol
and lipid build-up in the arteries of rats. "This is the first study to show that hibiscus extract has the same
effect." Hep B vaccine link to MS The team led by Dr Miguel Hernán of Boston's Harvard School of
Public Health studied 163 multiple sclerosis patients on the UK's General
Practice Research Database (comprising three million Britons) - looking
for cases of patients vaccinated against hepatitis B. "We estimated that immunisation against hepatitis B was associated
with a three-fold increase in the incidence of MS within the three years
following vaccination," Dr Hernán said. But he said it was important to consider the benefits of the vaccine
in preventing a potentially lethal infection. "Our study cannot distinguish whether the vaccine hastens the onset
of MS in persons destined to develop the disease years later, or whether
it causes new cases of MS in susceptible individuals," he said. "It is also important to stress that 93 percent of the MS cases
in our study had not been vaccinated." Researchers called for more research to explain the association between
hepatitis B vaccine and MS. Neurology September 14 2004 Alcohol may benefit heart but not gut According to a new study, men who drink halve their risk of having to
undergo a second treatment of balloon angioplasty. The treatment involves opening the arteries by the insertion of a tube
- inserted by a wire-controlled technique. But a second study warns sufferers of the condition ulcerative colitis
to avoid meat and alcohol. Reporting in the journal Heart, the researchers from Heidelburg University,
Germany, say that people with diabetes and non-drinkers are most likely
to need to have an angioplasty repeated within four months. More than 200 men took part in the study, of whome 172 drank more than
50 grams of alcohol a week. The study showed that just 23 per cent of the drinkers needed a repeat
procedure compared with 42 per cent of non-drinkers. Researcher Dr Christiane Tiefenbacher said the research "further
supports that moderate consumers of alcohol with an increased risk cardiovascular
risk profile should not be advised to stop drinking." The second study, in the journal Gut, finds that red meat and alcohol
triple the risk of a sufferer of the bowel condition, ulcerative colitis,
suffering a relapse. The findings come from a study of 183 patients in north east England. Researcher Dr Mark Welfare, of Newcastle University, says the cause of
the problem is sulphur, which is found in high protein foods, vegetables
such as broccoli and many alcoholic drinks. Cannabis trial hope A fifteen week trial of cannabis-based medicines had produced inconclusive
results. But after a year, researchers have now concluded that the effects of
at least one form of cannabis were positive. Researchers from the Peninsula Medical School, Plymouth, revealed their
latest findings at the British Association Science Festival in Exeter. More than 600 patients have been taking part in the trial, all seriously
disabled by the disease. The successful form of the drug has proved to be an extract, THC. Researcher Dr John Zajicek said the first phase of the trial had proved
difficult to evaluate because many patients correctly guessed they were
taking cannabis rather than a dummy drug. The latest findings were welcomed by the Royal Pharmaceutical Society
of Great Britain. Science secretary Dr John Clements said: "The RPSGB is delighted
with the encouraging results found in this study, showing evidence for
long-term benefits in easing the spasticity and disability associated
with MS. "We will continue to encourage research on cannabis as a medicine
as it is clear that cannabis-derived medicines have the potential to bring
great benefits to patients with MS."
Last Week
Contents
Need
News for Your Site?
FRIDAY
Books on Healthy
Eating
September 17 - People often bemoan the age of junk food - but in reality
most people have a much healthier diet than twenty years ago, according
to new findings.
FRIDAY
September 17 - New findings on Crohn's disease suggest that it could be
caused by a type of bacteria which causes a similar disease in certain
animals.
THURSDAY
September 16 - A charity set up by a battling doctor has declared its
intention to find a cure for haemophilia.
WEDNESDAY
September 15 - A popular herbal tea may have powerful anti-cholesterol
properties, it was announced today.
TUESDAY
September 14 - A vaccine against a liver virus could be associated with
a three-fold risk of developing multiple sclerosis, US researchers claim.
TUESDAY
Books
on Men's Health
September 14 - Men who undergo a common heart procedure can happily take
a few drinks of alcohol after treatment, researchers reported today.
MONDAY
September 13 - A British trial of cannabis as a treatment for multiple
sclerosis has not proved as disappointing as first thought, researchers
have reported.
Back to Title Page
Contents